Announcement on the Phase II Study on Voluntary Disclosure of the Safety, Tolerability and Initial Efficacy of Polyethylene Glycol Irinotecan as a Single Drug for Small Cell Lung Cancer
Announcement of reply to regulatory inquiry letter regarding information disclosure of 2023 annual report.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Jiankai Technology Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Notice on Using Idle Own Funds to Purchase Wealth Management Products
2024 Action Plan to Improve Quality, Increase Efficiency, and Value Rewards
Corporate Value and Return Promised Action Plan 2024
Announcement on the launch of foreign exchange hedging business
Notice on convening the 2023 Annual General Meeting of Shareholders
2023 Internal Control Evaluation Report
Report on the performance of the Audit Committee of the Board of Directors in 2023
Report on the performance of supervisory duties of accounting firms by the Audit Committee of the Board of Directors in 2023
Notice on requesting the shareholders' meeting to authorize the board of directors to issue shares to specific targets through simple procedures
Notice on acceptance of the application for voluntary disclosure of cross-linked sodium hyaluronate gel registration for injectable use
Announcement on the shareholding situation of the top ten shareholders and the top ten shareholders with unlimited sale conditions for share repurchases
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Legal Opinion of Beijing Zhonglun Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Beijing Jiankai Technology Co., Ltd.
2024 First Extraordinary General Meeting of Shareholders Meeting Materials
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
No Data
No Data